What is Menveo used for?

What is Menveo used for?

MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. MENVEO is approved for use in persons aged 2 months through 55 years.

What is difference between Menactra and Menveo?

Menveo is licensed for administration to individuals 2 months through 55 years of age, whereas Menactra is licensed for administration to individuals 9 months through 55 years of age. Menveo and Menactra and interchangeable for individuals aged 9 months and older.

Is menveo a meningitis vaccine?

Vaccines can help prevent meningococcal disease, which is any type of illness caused by Neisseria meningitidis bacteria. There are 2 types of meningococcal vaccines available in the United States: Meningococcal conjugate or MenACWY vaccines (Menactra®, Menveo®, and MenQuadfi®)

Is menveo and meningitis the same?

In the U.S., three meningococcal vaccines are available: Meningococcal polysaccharide vaccine (MPSV4), sold as Menomune. Meningococcal conjugate vaccine (MCV4), sold as Menactra, MenHibrix, and Menveo.

What does menveo protect against?

Menveo (meningococcal conjugate vaccine) is used to prevent infection caused by serogroups A, C, W, and Y. This vaccine helps your body develop immunity to meningitis. Meningococcal vaccine will not treat an active meningococcal infection that has already developed in the body.

Can you give Menactra after Menveo?

Give Menactra or Menveo booster after three years followed by boosters every five years thereafter. Give Menveo (if age 7 to 23 months)§ or Menactra (if age 9 to 23 months); administer two doses separated by three months. Give two doses of Menactra or Menveo two months apart.

What age can menveo be given?

CDC recommends infants 2 through 23 months of age with functional or anatomic asplenia or HIV receive Menveo®.

Is MenACWY a live vaccine?

It is also often seen in young people aged 15 to 19. It can safely be given at the same time as the Teenage Booster vaccine. Read more about multiple vaccinations and why these are not a risk to your child’s immune system. The vaccine does not contain any live bacteria, and it cannot cause meningococcal disease.

How long is menveo good for?

If primary vaccination is completed at age 7 years or older: give a booster dose every 5 years thereafter. For age 7 through 23 months who have not initiated a series of MenACWY-CRM Give 2 doses of Menveo. 3 Separate the 2 doses by at least 12 weeks.

Can Menveo and Bexsero be given together?

Yes. Menactra or Nimenrix and Bexsero can be administered at the same visit using different sites.

What should I know about Menveo before taking it?

Before taking this medicine. You should not receive a Menveo vaccine if you have ever had an allergic reaction to a meningococcal or a diphtheria vaccine. If you have any of these other conditions, your vaccine may need to be postponed or not given at all: pregnancy or breast-feeding;

What does meenveo stand for?

Menveo (meningococcal conjugate vaccine) is used to prevent meningococcal disease, an infection caused by meningococcal bacteria. These bacteria can infect the spinal cord and brain, causing meningitis that can be fatal.

What is menmenveo made from?

Menveo contains small amounts of oligosaccharides (a type of sugar) extracted from four groups of the N. meningitidis bacterium: A, C, W135 and Y. These have been purified, then ‘conjugated’ (attached) to a protein from the bacterium Corynebacterium diphtheriae.

When was Menveo approved in the European Union?

The European Commission granted a marketing authorisation valid throughout the European Union for Menveo on 15 March 2010. For more information about treatment with Menveo, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist. Please note that the size of the above document can exceed 50 pages.